|
2017 |
Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water |
Christopher Cartmell |
|
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Frank Porreca, PhD |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides. |
Todd Vanderah, PhD |
|
2017 |
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. |
John M. Streicher, PhD |
|
2017 |
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2016 |
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD |
|
2016 |
Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment. |
|
|
2016 |
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2016 |
Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. |
Nam Lee, Ph.D. |
|
2016 |
Neuroendocrinology: Oestrogen therapy affects brain structure but not function. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. |
Frank Porreca, PhD |
|
2016 |
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. |
John M. Streicher, PhD |
|
2016 |
Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. |
Jeffrey J. Lochhead, PhD |
|
2016 |
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Dynorphin A analogs for the treatment of chronic neuropathic pain. |
|
|
2016 |
Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. |
Frank Porreca, PhD |
|
2016 |
Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
